Web Flow - Login to access your portal

Compliance & Adherence Solutions

PCI is a leader in the area of compliance and adherence. We create adherence programs that are well designed, well executed, and truly measurable delivering better health and demonstrated ROI.

We develop programs that are comprehensive, taking into consideration the needs of the patient and disease state effectively boosting patient compliance and generating better health outcomes.

We work to develop the right solution for the application. This includes award-winning package design, facilitating opportunities to incorporate and integrate materials to address the many aspects of poor adherence. These may include:

  • Educational materials (printed and electronically)
  • Patient Assistance Programs (PAP)
  • Patient Diaries and Instructional guides
  • Tips for Lifestyle Improvement
  • Stickers and Reminder cards
  • Additional resources to promote improved health

Packaging styles support Physician Samples, Patient Starter Kits, Titration Therapies, as well as Child Resistant packaging (saleable Trade packaging) dispensed at pharmacy. F=1 Child Resistant / Senior Friendly packaging.

  • IntuiDoseTM
  • IntuiPacTM
  • AssuraDoseTM
  • DuraPacTM
  • HingePakTM
  • RxBarrierTM
  • Compliance In A Bottle (CIAB)TM
  • MWV Designs: ShellpakTTM, DosepakTM, Dosepak ExpressTM, PerfpakTM
  • Keystone: KeyPak, KeyPak Plus, EcoSlide
  • BurgoPak for the European market
  • Howell CR3
  • Colbert
  • Nosco Key-In
  • Intini Marketing

PCI has been recognized for outstanding and effective compliance designs receiving many awards.

 

 

Package types supported include:

Primary Packaging:

  • Blisters
  • Bottles
  • Pouches
  • Tubes

Secondary Packaging:

  • Labeling for Parenterals and Injectables
  • Tyvek Blistering for Parenterals
  • Device Assembly
  • Cartoning
  • Kitting
  • Child Resistant and Compliance Prompting Packaging
  • Overwrapping and Pouching
  • Walleting

Leave a Reply

Your email address will not be published. Required fields are marked *

2 − two =

Explore the PCI Process Phase by Phase

PRE-CLINICAL
PHASE I
PHASE II
PHASE III
COMMERCIAL

Swipe to explore the PCI Process

PRE CLINICAL

pre-clinical-icon
  • Formulation Development
  • Analytical development/characterisation

PHASE 1

PCI Phase 1
  • Formulation Development
  • Analytical Development
  • Drug in capsule/vial technology (Xcelodose)®
  • Phase I product manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase I packaging and labelling
  • Storage and distribution

PHASE 2

PCI Phase 2
  • Formulation Optimization
  • Dosage Form Process Validation
  • Analytical Testing and Stability Services
  • Phase II Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase II packaging and labelling
  • Storage and distribution

PHASE 3

PCI Phase 3
  • Comparator Sourcing
  • Scale Up Studies
  • Phase III Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase III packaging and labelling
  • Analytical testing and stability services
  • Storage and distribution

COMMERCIAL

PCI Commercial Phase
  • Scale up for commercial supply
  • Commercial product manufacture
  • Commercial packaging and labelling
  • Validation services
  • Analytical testing and stability services
  • Product release to market
  • Storage and distribution

PCI Points...

You told us what aspects you value as "very important" when choosing a vendor...

Why choose us...

Our global reach and localized support ensures PCI as a strategic partner remains focussed on delivering speed-to-market and the commercial success of our customers

PCI is a global company that focusses on delivering speed-to-market and the commercial success of our customers

Why choose us...